Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 162

1.

Selection of effective HTRA3 activators using combinatorial chemistry.

Wysocka M, Sychowska K, Gruba N, Winiarski Ł, Skoreński M, Psurski M, Makowska J, Gieldon A, Wenta T, Jarząb M, Glaza P, Zdacewicz J, Sieńczyk M, Lipinska B, Lesner A.

ACS Comb Sci. 2017 Jul 25. doi: 10.1021/acscombsci.7b00051. [Epub ahead of print]

PMID:
28741928
2.

Long term changes in the concentration of radium in discharge waters of coal mines and Upper Silesian rivers.

Chałupnik S, Wysocka M, Janson E, Chmielewska I, Wiesner M.

J Environ Radioact. 2017 May;171:117-123. doi: 10.1016/j.jenvrad.2017.02.007. Epub 2017 Feb 22.

PMID:
28235699
3.

Gain of CD26 expression on the malignant T-cells in relapsed erythrodermic leukemic mycosis fungoides.

Cedeno-Laurent F, Wysocka M, Obstfeld AE, Novoa RA, Vittorio CC, Kim EJ, Weng WK, Rook AH.

J Cutan Pathol. 2017 May;44(5):462-466. doi: 10.1111/cup.12899. Epub 2017 Feb 10.

PMID:
28083948
4.

Substrate profiling of Zika virus NS2B-NS3 protease.

Gruba N, Rodriguez Martinez JI, Grzywa R, Wysocka M, Skoreński M, Burmistrz M, Łęcka M, Lesner A, Sieńczyk M, Pyrć K.

FEBS Lett. 2016 Oct;590(20):3459-3468. doi: 10.1002/1873-3468.12443. Epub 2016 Oct 18.

PMID:
27714789
5.

TIGIT and Helios Are Highly Expressed on CD4+ T Cells in Sézary Syndrome Patients.

Jariwala N, Benoit B, Kossenkov AV, Oetjen LK, Whelan TM, Cornejo CM, Takeshita J, Kim BS, Showe LC, Wysocka M, Rook AH.

J Invest Dermatol. 2017 Jan;137(1):257-260. doi: 10.1016/j.jid.2016.08.016. Epub 2016 Sep 1. No abstract available.

6.

CD164 identifies CD4+ T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214.

Benoit BM, Jariwala N, O'Connor G, Oetjen LK, Whelan TM, Werth A, Troxel AB, Sicard H, Zhu L, Miller C, Takeshita J, McVicar DW, Kim BS, Rook AH, Wysocka M.

Arch Dermatol Res. 2017 Jan;309(1):11-19. doi: 10.1007/s00403-016-1698-8. Epub 2016 Oct 20.

PMID:
27766406
7.

Inhibitors and Antibody Fragments as Potential Anti-Inflammatory Therapeutics Targeting Neutrophil Proteinase 3 in Human Disease.

Korkmaz B, Lesner A, Guarino C, Wysocka M, Kellenberger C, Watier H, Specks U, Gauthier F, Jenne DE.

Pharmacol Rev. 2016 Jul;68(3):603-30. doi: 10.1124/pr.115.012104. Review.

8.

Bladder cancer detection using a peptide substrate of the 20S proteasome.

Gruba N, Wysocka M, Brzezińska M, Dębowski D, Sieńczyk M, Gorodkiewicz E, Guszcz T, Czaplewski C, Rolka K, Lesner A.

FEBS J. 2016 Aug;283(15):2929-48. doi: 10.1111/febs.13786. Epub 2016 Jul 14.

PMID:
27326540
9.

PEGylated substrates of NSP4 protease: A tool to study protease specificity.

Wysocka M, Gruba N, Grzywa R, Giełdoń A, Bąchor R, Brzozowski K, Sieńczyk M, Dieter J, Szewczuk Z, Rolka K, Lesner A.

Sci Rep. 2016 Mar 9;6:22856. doi: 10.1038/srep22856.

10.

Intra- and intersubunit changes accompanying thermal activation of the HtrA2(Omi) protease homotrimer.

Jarzab M, Wenta T, Zurawa-Janicka D, Polit A, Gieldon AJ, Wysocka M, Glaza P, Skorko-Glonek J, Ciarkowski J, Lesner A, Lipinska B.

Biochim Biophys Acta. 2016 Mar;1864(3):283-96. doi: 10.1016/j.bbapap.2015.12.002. Epub 2015 Dec 15.

PMID:
26702898
11.

Novel internally quenched substrate of the trypsin-like subunit of 20S eukaryotic proteasome.

Gruba N, Wysocka M, Brzezińska M, Debowski D, Rolka K, Martin NI, Lesner A.

Anal Biochem. 2016 Sep 1;508:38-45. doi: 10.1016/j.ab.2015.08.019. Epub 2015 Aug 24.

PMID:
26314791
12.

Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma.

Rook AH, Gelfand JM, Wysocka M, Troxel AB, Benoit B, Surber C, Elenitsas R, Buchanan MA, Leahy DS, Watanabe R, Kirsch IR, Kim EJ, Clark RA.

Blood. 2015 Sep 17;126(12):1452-61. doi: 10.1182/blood-2015-02-630335. Epub 2015 Jul 30. Erratum in: Blood. 2015 Dec 17;126(25):2765. Gelfand, Joel C [corrected to Gelfand, Joel M].

13.

Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities.

Cedeno-Laurent F, Singer EM, Wysocka M, Benoit BM, Vittorio CC, Kim EJ, Yosipovitch G, Rook AH.

Clin Immunol. 2015 May;158(1):1-7. doi: 10.1016/j.clim.2015.02.014. Epub 2015 Mar 8.

14.

Design and synthesis of new substrates of HtrA2 protease.

Wysocka M, Wojtysiak A, Okońska M, Gruba N, Jarząb M, Wenta T, Lipińska B, Grzywa R, Sieńczyk M, Rolka K, Lesner A.

Anal Biochem. 2015 Apr 15;475:44-52. doi: 10.1016/j.ab.2015.01.013. Epub 2015 Jan 29.

PMID:
25640585
15.

New selective peptidyl di(chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases.

Guarino C, Legowska M, Epinette C, Kellenberger C, Dallet-Choisy S, Sieńczyk M, Gabant G, Cadene M, Zoidakis J, Vlahou A, Wysocka M, Marchand-Adam S, Jenne DE, Lesner A, Gauthier F, Korkmaz B.

J Biol Chem. 2014 Nov 14;289(46):31777-91. doi: 10.1074/jbc.M114.591339. Epub 2014 Oct 6.

16.

Synthesis of novel phosphonic-type activity-based probes for neutrophil serine proteases and their application in spleen lysates of different organisms.

Grzywa R, Burchacka E, Łęcka M, Winiarski Ł, Walczak M, Łupicka-Słowik A, Wysocka M, Burster T, Bobrek K, Csencsits-Smith K, Lesner A, Sieńczyk M.

Chembiochem. 2014 Nov 24;15(17):2605-12. doi: 10.1002/cbic.201402360. Epub 2014 Sep 18.

PMID:
25236966
17.

Eating habits of patients with cleft lip and palate terated with fixed appliances.

Wysocka M, Cudziło D, Kawala B, Kopczyński P.

Dev Period Med. 2014;18(1):93-101.

18.

Ultrasensitive internally quenched substrates of human cathepsin L.

Lęgowska M, Wysocka M, Burster T, Pikuła M, Rolka K, Lesner A.

Anal Biochem. 2014 Dec 1;466:30-7. doi: 10.1016/j.ab.2014.08.010. Epub 2014 Aug 23.

PMID:
25151941
19.

Substrate profiling of Finegoldia magna SufA protease, inhibitor screening and application to prevent human fibrinogen degradation and bacteria growth in vitro.

Burchacka E, Sieńczyk M, Frick IM, Wysocka M, Lesner A, Oleksyszyn J.

Biochimie. 2014 Aug;103:137-43. doi: 10.1016/j.biochi.2014.05.006. Epub 2014 May 22.

PMID:
24859537
20.

Fluorescent analogs of trypsin inhibitor SFTI-1 isolated from sunflower seeds--synthesis and applications.

Lesner A, Karna N, Psurski M, Lęgowska A, Wysocka M, Guzow K, Sieradzan A, Sieńczyk M, Trzonkowski P, Pikuła M, Zieliński M, Kosikowska P, Łukajtis R, Łęgowska M, Dębowski D, Wiczk W, Rolka K.

Biopolymers. 2014 Jan;102(1):124-35. doi: 10.1002/bip.22442.

PMID:
24272319

Supplemental Content

Loading ...
Support Center